Inventor
DEAVER DANIEL
US17 patents
⚠️ This page may combine multiple inventors who share the name “DEAVER DANIEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALKERMES PHARMA IRELAND LTD
14 patentsUS8822488B2Sep 2, 2014
Compositions of buprenorphine and μ antagonists
ALKERMES PHARMA IRELAND LTD57 citations97
US9211293B2Dec 15, 2015
Opioid agonist antagonist combinations
ALKERMES PHARMA IRELAND LTD49 citations93
US10716785B2Jul 21, 2020
Methods for treating antipsychotic-induced weight gain
ALKERMES PHARMA IRELAND LTD8 citations92
US10300054B2May 28, 2019
Methods for treating antipsychotic-induced weight gain
ALKERMES PHARMA IRELAND LTD11 citations92
US9943514B2Apr 17, 2018
Methods for treating antipsychotic-induced weight gain
ALKERMES PHARMA IRELAND LTD10 citations92
US9517235B2Dec 13, 2016
Methods for treating antipsychotic-induced weight gain
ALKERMES PHARMA IRELAND LTD13 citations92
US9126977B2Sep 8, 2015
Methods for treating antipsychotic-induced weight gain
ALKERMES PHARMA IRELAND LTD13 citations92
US9918978B2Mar 20, 2018
Compositions of buprenorphine and μ antagonists
ALKERMES PHARMA IRELAND LTD3 citations83
US9498474B2Nov 22, 2016
Compositions of buprenorphine and μ Antagonists
ALKERMES PHARMA IRELAND LTD6 citations83
US10314838B2Jun 11, 2019
Compositions of buprenorphine and μ antagonists
ALKERMES PHARMA IRELAND LTD2 citations72
US9913837B2Mar 13, 2018
Compositions of buprenorphine and μ antagonists
ALKERMES PHARMA IRELAND LTD3 citations72
US10758527B2Sep 1, 2020
Opioid agonist antagonist combinations
ALKERMES PHARMA IRELAND LTD0 citations51
US10195191B2Feb 5, 2019
Opioid agonist antagonist combinations
ALKERMES PHARMA IRELAND LTD0 citations51
US10188643B2Jan 29, 2019
Compositions of buprenorphine and μ antagonists
ALKERMES PHARMA IRELAND LTD0 citations51